149 related articles for article (PubMed ID: 14561610)
1. Perfusion- and diffusion-weighted MR imaging-guided therapy of vertebral artery dissection: intraarterial thrombolysis through an occipital vertebral anastomosis.
Restrepo L; Pradilla G; Llinas R; Beauchamp NJ
AJNR Am J Neuroradiol; 2003 Oct; 24(9):1823-6. PubMed ID: 14561610
[TBL] [Abstract][Full Text] [Related]
2. Combined thrombolysis in posterior circulation stroke caused by bilateral vertebral artery dissection in squash player.
Frankowska E; Brzozowski K; Staszewski J; Kolmaga N; Stępień A; Bogusławska-Walecka R
Neurol Neurochir Pol; 2014; 48(4):299-304. PubMed ID: 25168332
[TBL] [Abstract][Full Text] [Related]
3. Perfusion-weighted imaging/diffusion-weighted imaging mismatch on MRI can now be used to select patients for recombinant tissue plasminogen activator beyond 3 hours: pro.
Schellinger PD; Fiebach JB
Stroke; 2005 May; 36(5):1104-5. PubMed ID: 15790944
[No Abstract] [Full Text] [Related]
4. Perfusion-weighted imaging/diffusion-weighted imaging mismatch on MRI can now be used to select patients for recombinant tissue plasminogen activator beyond 3 hours: con.
Zivin JA
Stroke; 2005 May; 36(5):1105-6. PubMed ID: 15790943
[No Abstract] [Full Text] [Related]
5. Locked in and out: a case of emerging basilar artery obstruction secondary to vertebral artery dissection thrombolysed with intravenous rt-PA.
Al-Raweshidy YH; Sinha DM; Coward LJ; Guyler PC; O'Brien A
BMJ Case Rep; 2011 May; 2011():. PubMed ID: 22696744
[TBL] [Abstract][Full Text] [Related]
6. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
7. Can baseline magnetic resonance angiography (MRA) status become a foremost factor in selecting optimal acute stroke patients for recombinant tissue plasminogen activator (rt-PA) thrombolysis beyond 3 hours?
Ma L; Gao PY; Lin Y; Xue J; Wang XC; Wang YJ; Wang YL; Liao XL; Liu ML; Cui SM; Yu L; Tong SJ; Huang YL; Zhou YM
Neurol Res; 2009 May; 31(4):355-61. PubMed ID: 19508818
[TBL] [Abstract][Full Text] [Related]
8. Diffusion- and perfusion-weighted MRI response to thrombolysis in stroke.
Parsons MW; Barber PA; Chalk J; Darby DG; Rose S; Desmond PM; Gerraty RP; Tress BM; Wright PM; Donnan GA; Davis SM
Ann Neurol; 2002 Jan; 51(1):28-37. PubMed ID: 11782981
[TBL] [Abstract][Full Text] [Related]
9. The Use of Tissue Plasminogen Activator in the Treatment of Wallenberg Syndrome Caused by Vertebral Artery Dissection.
Salerno A; Cotter BV; Winters ME
J Emerg Med; 2017 May; 52(5):738-740. PubMed ID: 28258876
[TBL] [Abstract][Full Text] [Related]
10. Combined intravenous and intraarterial revascularization therapy using MRI perfusion/diffusion mismatch selection for acute ischemic stroke at 3-6 h after symptom onset.
Han MK; Kim SH; Ko SB; Paik NJ; Kwon OK; Lee YS; Oh CW; Kim JH; Park SH; Bae HJ
Neurocrit Care; 2008; 8(3):353-9. PubMed ID: 18340411
[TBL] [Abstract][Full Text] [Related]
11. Clinical and radiological factors associated with unfavorable outcome after intravenous thrombolysis in patients with mild ischemic stroke.
Kim DH; Lee DS; Nah HW; Cha JK
BMC Neurol; 2018 Mar; 18(1):30. PubMed ID: 29544461
[TBL] [Abstract][Full Text] [Related]
12. Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI.
Schellinger PD; Jansen O; Fiebach JB; Heiland S; Steiner T; Schwab S; Pohlers O; Ryssel H; Sartor K; Hacke W
Stroke; 2000 Jun; 31(6):1318-28. PubMed ID: 10835451
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment diffusion-weighted imaging lesion volume predicts favorable outcome after intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke.
Kruetzelmann A; Köhrmann M; Sobesky J; Cheng B; Rosenkranz M; Röther J; Schellinger PD; Ringleb P; Gerloff C; Fiehler J; Thomalla G
Stroke; 2011 May; 42(5):1251-4. PubMed ID: 21415399
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of systemic thrombolysis within 4.5 h from stroke symptom onset: a single-centre clinical and diffusion-perfusion 3T MRI study.
Floris R; Cozzolino V; Meschini A; Garaci F; Konda D; Marziali S; Sallustio F; Di Legge S; Claroni G; Fanucci E; Simonetti G; Stanzione P
Radiol Med; 2014 Oct; 119(10):767-74. PubMed ID: 24567091
[TBL] [Abstract][Full Text] [Related]
15. Using mismatch on MRI to select thrombolytic responders: an attractive hypothesis awaiting confirmation.
Davis SM; Donnan GA
Stroke; 2005 May; 36(5):1106-7. PubMed ID: 15802638
[No Abstract] [Full Text] [Related]
16. High-resolution magnetic resonance imaging reveals hidden etiologies of symptomatic vertebral arterial lesions.
Chung JW; Kim BJ; Choi BS; Sohn CH; Bae HJ; Yoon BW; Lee SH
J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):293-302. PubMed ID: 23541422
[TBL] [Abstract][Full Text] [Related]
17. Complete recovery after early intraarterial recombinant tissue plasminogen activator thrombolysis of carotid T occlusion.
Rabinstein AA; Wijdicks EF; Nichols DA
AJNR Am J Neuroradiol; 2002 Oct; 23(9):1596-9. PubMed ID: 12372754
[TBL] [Abstract][Full Text] [Related]
18. Combined stent placement and thrombolysis in acute vertebrobasilar ischemic stroke.
Lin DD; Gailloud P; Beauchamp NJ; Aldrich EM; Wityk RJ; Murphy KJ
AJNR Am J Neuroradiol; 2003 Oct; 24(9):1827-33. PubMed ID: 14561611
[TBL] [Abstract][Full Text] [Related]
19. Intraarterial thrombolysis within the first three hours after acute ischemic stroke in selected patients.
Moonis M
Stroke; 2009 Jul; 40(7):2611-2. PubMed ID: 19443796
[No Abstract] [Full Text] [Related]
20. Endovascular stent-assisted thrombolysis in acute occlusive carotid artery dissection.
Mourand I; Brunel H; Vendrell JF; Thouvenot E; Bonafé A
Neuroradiology; 2010 Feb; 52(2):135-40. PubMed ID: 19756560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
